Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Nilotinib hydrochloride

Catalog No. T22378Cas No. 923288-95-3
Alias AMN-107 HCl

Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.

Nilotinib hydrochloride

Nilotinib hydrochloride

Purity: 100%
Catalog No. T22378Alias AMN-107 HClCas No. 923288-95-3
Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.
Pack SizePriceAvailabilityQuantity
5 mg$40In Stock
10 mg$57In Stock
25 mg$94In Stock
50 mg$138In Stock
100 mg$209In Stock
500 mg$593In Stock
1 mL x 10 mM (in DMSO)$96In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Nilotinib hydrochloride"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.
Targets&IC50
BCR-ABL:<30 nM
In vitro
Nilotinib hydrochloride (AMN107 hydrochloride) is a selective Abl inhibitor designed to interact with the ATP binding site of BCR-ABL with higher affinity than imatinib while being more potent than imatinib (IC50<30 nM ), also retains activity against most BCR-ABL point mutants that confer resistance to imatinib.[1]
Nilotinib hydrochloride showed significant anti-tumor efficacy against GIST xenograft cell lines and imatinib-resistant GIST cell lines, among which the parental cell lines GK1C and GK3C showed imatinib sensitivity with IC50 of 4.59±0.97 μM and 11.15±1.48 μM, respectively.[2]
In vivo
Nilotinib hydrochloride (AMN107 hydrochloride) (40 mg/kg; oral gavage; daily; for 4 weeks; BALB/cSLc-nu/nu mice with GIST xenograft) demonstrated equivalent or superior antitumor effects in BALB/cSLc-nu/nu mice with GIST xenografts. Nilotinib hydrochloride Inhibited tumor growth by 69.6% in GK1X, 85.3% in GK2X, and 47.5% in GK3X xenograft line.[2]
Nilotinib hydrochloride exerts significant healing effects on macroscopic and microscopic pathology scores in a rat model of indomethacin-induced enterocolitis and ensures considerable mucosal healing while reducing PDGFR alpha and beta levels and apoptosis in the colon Rating.[3]
AliasAMN-107 HCl
Chemical Properties
Molecular Weight565.98
FormulaC28H23ClF3N7O
Cas No.923288-95-3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 90 mg/ml (159.02 mM)
Ethanol: 1 mg/ml (1.77 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM1.7668 mL8.8342 mL17.6685 mL88.3423 mL
DMSO
1mg5mg10mg50mg
5 mM0.3534 mL1.7668 mL3.5337 mL17.6685 mL
10 mM0.1767 mL0.8834 mL1.7668 mL8.8342 mL
20 mM0.0883 mL0.4417 mL0.8834 mL4.4171 mL
50 mM0.0353 mL0.1767 mL0.3534 mL1.7668 mL
100 mM0.0177 mL0.0883 mL0.1767 mL0.8834 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Nilotinib hydrochloride | purchase Nilotinib hydrochloride | Nilotinib hydrochloride cost | order Nilotinib hydrochloride | Nilotinib hydrochloride chemical structure | Nilotinib hydrochloride in vivo | Nilotinib hydrochloride in vitro | Nilotinib hydrochloride formula | Nilotinib hydrochloride molecular weight